Get started
Author

Jessica Maitland

Observed names: J. Maitland, Maitland, Jessica
ORCID: 0009-0002-6804-319X
Observed ORCID: 0009-0002-6804-319X
OpenAlex ID: A5005258531
The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective
2022 · Lori L. Davis, Jeff Schein, et al. · The Journal of Clinical Psychiatry · 290
PDF
The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)
2023 · Paul Greenberg, Abhishek Chitnis, et al. · Advances in Therapy · 257
PDF
Tracking Cross-Contamination Transfer Dynamics at a Mock Retail Deli Market Using GloGerm
2013 · Jessica Maitland, Renee Boyer, et al. · Journal of Food Protection · 31
Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States – a retrospective claims analysis
2022 · Jeff Schein, Ann Childress, et al. · BMC Psychiatry · 24
Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study
2021 · Jeff Schein, Ann Childress, et al. · Current Medical Research and Opinion · 23
Real-World Outcomes of Elacestrant in ER+, HER2−, ESR1 -Mutant Metastatic Breast Cancer
2025 · Hope S. Rugo, Virginia Kaklamani, et al. · Clinical Cancer Research · 18
PDF
Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis
2023 · Jeff Schein, Ann Childress, et al. · Advances in Therapy · 12
PDF
Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States
2021 · Cynthia Willey, Marjolaine Gauthier-Loiselle, et al. · Current Medical Research and Opinion · 12
PDF
Real-World Trends and Future Projections of the Prevalence of Cirrhosis and Hepatic Encephalopathy Among Commercially and Medicare-Insured Adults in the United States
2025 · Robert J. Wong, Patrick Gagnon-Sanschagrin, et al. · Clinical and Translational Gastroenterology · 10
Impact of living with an adult with depressive symptoms among households in the United States
2023 · Paul Greenberg, Lasair O'Callaghan, et al. · Journal of Affective Disorders · 8
Comparative Effectiveness of Venetoclax Combinations Vs Other Therapies Among Patients with Newly Diagnosed Acute Myeloid Leukemia: Results from the AML Real World Evidence (ARC) Initiative
2021 · Jacqueline S. Garcia, Ofir Wolach, et al. · Blood · 7
Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States – a retrospective claims study
2023 · Lori L. Davis, Annette Urganus, et al. · Current Medical Research and Opinion · 6
PDF
Mental Health and Health-Related Quality of Life Among Nephrology Nurses: A Survey-Based Cross-Sectional Study
2021 · Vicki Montoya, Katie Donnini, et al. · Nephrology Nursing Journal · 6
Abstract P3-10-08: Elacestrant real-world progression-free survival (rwPFS) of adult patients with ER+/HER2-, advanced breast cancer: a retrospective analysis using insurance claims in the United States
2025 · Elyse Swallow, Jessica Maitland, et al. · Clinical Cancer Research · 4
Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative
2021 · Pankit Vachhani, Ofir Wolach, et al. · Blood · 4
Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases
2026 · Surbhi Sidana, Saurabh P. Nagar, et al. · Oncology and Therapy · 3
PDF
Assessment of Access Barriers to Rifaximin Among Patients with Hepatic Encephalopathy Using Adjudicated Claims Data
2025 · Arun Jesudian, Patrick Gagnon-Sanschagrin, et al. · Advances in Therapy · 3
PDF
Real-world incidence and management of non-icans neurologic events following ciltacabtagene autoleucel in multiple myeloma
2025 · Doris Hansen, Omar Alexis Castaneda Puglianini, et al. · Blood · 2
PDF
Patient Characteristics, Treatment Patterns and Early Outcomes of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Initiated on Talquetamab: An Electronic Medical Record and Chart Review Study
2024 · Cesar Rodriguez, Hsien-Yen Chang, et al. · Blood · 2
PDF
Patient journey of civilian adults diagnosed with posttraumatic stress disorder—A chart review study
2024 · Lori L. Davis, Annette Urganus, et al. · Current Medical Research and Opinion · 2
PDF
Comparison of Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated with Venetoclax and Hypomethylating Agents Vs Other Therapies By TP53 and IDH1/2 Mutation: Results from the AML Real World Evidence (ARC) Initiative
2022 · Ofir Wolach, Jacqueline S. Garcia, et al. · Blood · 2
Opioid-Induced Constipation: Cost Impact of Approved Medications in the Emergency Department
2022 · W. Frank Peacock, Neal Slatkin, et al. · Advances in Therapy · 2
PDF
Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple Myeloma
2026 · Doris Hansen, Omar Castaneda Puglianini, et al. · Clinical Epidemiology · 1
PDF
Real-world healthcare resource utilization and clinical outcomes among patients with relapsed/refractory multiple myeloma receiving ciltacabtagene autoleucel after four or more prior lines of therapy in inpatient versus outpatient settings
2026 · Murali Janakiram, Lin Fan, et al. · Journal of Medical Economics · 1
Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptoms
2026 · Doris K. Hansen, Omar Alexis Castaneda Puglianini, et al. · Current Medical Research and Opinion · 1
PDF
Works count: 52
Citation count: 734
H-index: 9
I10-index: 9
Year
Topic
Type